SoftBank has made a somewhat surprising choice in its bid to pour billions into biotech and healthcare.
The Japanese behemoth has quietly acquired a $5 billion stake in Roche, making it one of the Swiss pharma giant’s largest investors, Bloomberg reported. The Financial Times later...
